Abstract
This article summarizes 15 years of clinical and laboratory studies that have continued the search for a biochemical basis for the development and resolution of symptomatic benign fibrocystic disease. The clinical response to diet modifications is presented along with simultaneous laboratory tissue and serum studies. An ongoing study of the clinical response to complete and total methylxanthine abstention, especially caffeine, is presented in the initial part of the article. Following the clinical observations, is a series of laboratory studies, some of which actually preceded the clinical investigation and, in fact, pointed out that a beneficial clinical response might occur in some women following complete abstention. In the last paragraph, we present current information that may identify which women are susceptible to fibrocystic breast disease development.
Résumé
Les auteurs résument ici leur expérience clinique et biologique de 15 ans: le but est de trouver une base biochimique du développement et de la résolution de la maladie fibrokystique bénigne symptomatique du sein. La réponse clinique aux modifications diététiques, accompagnée d'études simultanées tissulaires et sanguines, est présentée. Au début de cet article, on présente les résultats d'une étude toujours en cours, sur la réponse clinique à l'abstention complète des composés à base de méthylxanthines, notamment la caféine. Après les cas cliniques, on trouve une série d'études de laboratoire, dont certaines avaient précédé les investigations cliniques: elles avaient, d'ailleurs, indiqué que la réponse à l'abstention complète pouvait être positive chez certaines femmes. Enfin, on présente les données récentes qui peuvent aider à identifier les femmes susceptibles de développer la maladie fibrokystique bénigne du sein.
Resumen
Este artículo resume 15 años de estudios clínicos y de laboratorio que han continuado la búsqueda de un fundamento bioquímico para el desarrollo y resolución de la enfermedad fibroquística. La respuesta clínica a las modificaciones dietarias es presentada al tiempo con estudios de laboratorio de tejidos y de suero. Se reporta, en la parte inicial del artículo, un estudio en progreso sobre la respuesta clínica a la abstención completa y total de metilxantina, específicamente de cafeína. A continuación de las observaciones clínicas, aparece una serie de estudios de laboratorio, algunos de los cuales precedieron a la investigación clínica y realmente señalaron que se puede presentar una respuesta clínica beneficiosa en algunas mujeres mediante la abstención completa. En el último parágrafo presentamos información actual capaz de identificar cuáles mujeres son susceptibles de desarrollar enfermedad fibroquística de los senos.
Similar content being viewed by others
References
Minton, J.P., Foecking, M.K., Webster, D.J.T., Matthews, R.H.: Response of fibrocystic disease to caffeine withdrawal and correlation of cyclic nucleotides with breast disease. Am. J. Obstet. Gynecol.135:157, 1979
Minton, J.P., Abou-Issa, H., Reiches, N., Roseman, J.M.: Biochemical and clinical studies on methylxanthine-related fibrocystic breast disease. Surgery90:299, 1981
Minton, J.P., Abou-Issa, H., Elliott, J.B., Foecking, M.K., Roseman, J.M., Matthews, R.H.: Biochemical subgrouping of benign breast disease to define premalignant potential. Surgery90:652, 1982
Abou-Issa, H., Bronn, D.G., Minton, J.P., Moosa, S., Couri, D.: In vivo and in vitro effects of caffeine on cyclic nucleotide metabolism in mammary tissue. Fed. Proc.40:665, 1981
Foecking, M.K., Abou-Issa, H., Minton, J.P.: Properties and characteristics of adenylate cyclase in normal and fibrocystic epithelial cells. Fed. Proc.14:1409, 1982
Brooks, P.G., Gart, S., Heldfond, A.G., Margolin, M.L., Allen, A.S.: Measuring the effect of caffeine restriction on fibrocystic breast disease: The role of graphic stress teletheromometry as an objective monitor of the disease. J. Reprod. Med.26:279, 1981
La Vecchia, C., Franceschi, S., Parazzini, F., Regallo, M., Decarli, A., Gallus, G., DiPietro, S., Tognoni, G.: Benign breast disease and consumption of beverages containing methylxanthines. J. Natl. Cancer Inst.74:995, 1985
Boyle, C.A., Berkowitz, G.S., Li Volsi, V.A., Ort, S., Merino, M.Z.: Caffeine consumption and fibrocystic breast disease: A case-control epidemiological study. J. Natl. Cancer Inst.72:1015, 1984
Lubin, F., Ron, E., Wax, Y., Modan, B.: Coffee and methylxanthines and breast cancer: A case-control study. J. Natl. Cancer Inst.74:569, 1985
Allen, S.S., Froberg, D.G.: The effect of decreased caffeine consumption on benign proliferative breast disease. A randomized clinical trial. Surgery101:720, 1987
Lubin, F., Ron, E., Wax, Y., Black, M., Funaro, M., Shirit, A.: A case-control study of caffeine and methylxanthines in benign breast disease. J. Am. Med. Assoc.253:2388, 1985
Levinson, W., Dunn, P.M.: Nonassociation of caffeine and fibrocystic breast disease. Arch. Intern. Med.146:1773, 1986
Spindel, E., Arnold, M., Cusack, B., Wurtman, R.Z.: Effects of caffeine on anterior pituitary and thyroid hormones in the rat. J. Pharmocol. Exp. Ther.214:58, 1980
Schlosberg, A.J., Fernstrom, J.D., Kopczynski, M.C., Cusack, B.M., Gillis, M.A.: Acute effects of caffeine injection on neutral amino acids and brain monoamine levels. Life Sci.29:173, 1981
Krantz, J.C., Carr, J.C., editors: The pharmacologic principles of medical practice, Baltimore, Williams and Wilkins Co., 1969
Golinger, R.C.: Hormones and pathophysiology of fibrocystic mastopathy. Surg. Gynecol. Obstet.146:273, 1978
Minton, J.P.: Dietary factors in benign breast disease. The Cancer Bull.40:44, 1988
Bar, H.: Epinephrine and prostaglandin-sensitive adenyl cyclase in mammary gland. Biochem. Biophys. Acta321:397, 1973
Minton, J.P., Abou-Issa, H.: Fibrocystic breast disease, its management and explanation. In Advances in Breast and Endocrine Surgery, J.S. Najarian, J.P. Delaney, editors, Chicago, Year Book Medical Publishers, Inc., 1986, pp. 15–24
Arsiriy, S.A.: Urine catecholamine content in patients with malignant and benign breast neoplasms. Vopt. Onkol.15:50, 1969
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Minton, J.P., Abou-Issa, H. Nonendocrine theories of the etiology of benign breast disease. World J. Surg. 13, 680–684 (1989). https://doi.org/10.1007/BF01658414
Issue Date:
DOI: https://doi.org/10.1007/BF01658414